The coverage expansion strengthens the reimbursement runway for SWIFT, supporting future revenue growth. Monitor upcoming quarterly results for evidence of volume acceleration and any competitive responses from alternative TMS or neurostimulation companies.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 22 $14.38entry
- T+1 · 5mo ago +0.07%α +1.52% · $14.39
- T+5 · 5mo ago +5.49%α +5.95% · $15.17
- T+20 · 4mo ago +9.39%α +9.54% · $15.73
- T+60 · 2mo ago −6.40%α −8.14% · $13.46
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
BrainsWay announced expanded favorable insurance coverage for its SWIFT Accelerated Deep TMS protocol, now covering over 57 million covered lives across eight major payers and the VA. This milestone improves reimbursement access and supports future revenue growth.
Key Facts
- Coverage expanded to over 57 million covered lives for SWIFT Accelerated Deep TMS
- Eight major payers and the US Department of Veterans Affairs now cover or support accelerated TMS treatment approaches
- Latest policy change adds 2 million members in South Carolina
- Follows strong 2025 annual results: 27% revenue growth to $52.2M and net income of $7.6M (per cross-filing 20-F)
Financial Impact
Expanded coverage likely to drive incremental revenue from increased patient access and procedure volumes; no specific revenue impact quantified in filing
Risk Factors
- Competing TMS technologies and potential market share erosion
- Ongoing patent litigation with Magnus Medical as noted in prior annual report
- Reimbursement changes or delays from additional payers
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-004211 |
| Document: f6k_062126.htm | 0001171843-26-004211 |
| Document: 0001171843-26-004211-index-headers.html | 0001171843-26-004211 |
| Document: 0001171843-26-004211-index.html | 0001171843-26-004211 |
| Document: 0001171843-26-004211.txt | 0001171843-26-004211 |
Track record
24 reports on BWAY
5 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +27.55% at T+60 after the Mar 4, 2026 report. 7 of 10 went positive at some point.
Filters
- Nov 10, 20266d ago 6-K Bullish 6/10 No price data
- Nov 10, 20266d ago 6-K Neutral 5/10 Entry $10.67 Now $9.39 −12.00% settles Dec 9
- Nov 2, 202614d ago 6-K Neutral 3/10 Entry $11.09 Now $9.39 −15.33% settles Dec 1
- Nov 2, 202614d ago Press Release Neutral 3/10 Entry $11.09 Now $9.39 −15.33% settles Dec 1
- Oct 26, 202621d ago 6-K Neutral 3/10 Entry $11.21 Now $9.39 −16.24% settles Nov 23
- Oct 21, 202626d ago 6-K Neutral 3/10 Entry $11.44 Now $9.39 −17.92% settles Nov 19
- Oct 19, 202628d ago 6-K Neutral 3/10 Entry $11.99 to $9.39 Now $9.39 −21.68% ▼ −21.68% −18.22% vs SPY
- Oct 19, 202628d ago Press Release Neutral 4/10 Entry $11.99 to $9.39 Now $9.39 −21.68% ▼ −21.68% −18.22% vs SPY
- Oct 13, 20264w ago 6-K Neutral 4/10 Entry $11.92 to $10.67 Now $9.39 −21.22% ▼ −10.49% −6.88% vs SPY
- Sep 8, 20269w ago 6-K Neutral 4/10 Entry $14.16 to $11.89 Now $9.39 −33.69% ▼ −16.03% −18.00% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers